GE Healthcare and G-CON create platform for advanced therapy production
GE Healthcare and G-CON have combined capabilities to offer drug developers ‘readily deployable’ manufacturing platforms for cell therapies and viral vectors.
Archives for January 24, 2019
Immunomedics receives FDA complete response letter
Immunomedics received a complete response letter from the US FDA for its BLA seeking approval of its biologic, sacituzumab govitecan.